Altered functional network topology correlates with clinical measures in very early-stage, drug-naïve Parkinson's disease
- 1 May 2019
- journal article
- research article
- Published by Elsevier in Parkinsonism & Related Disorders
- Vol. 62, 3-9
Abstract
No abstract availableKeywords
Funding Information
- NIH (1R01EB014284)
- COBRE (1P20GM109025-01A1)
- Elaine P Wynn and Family Foundation
- Sam and Peggy Grossman Foundation
- Samuel P. Mandell Foundation
- Michael J. Fox Foundation
- AbbVie
- Avid Radiopharmaceuticals
- Biogen Idec
- Bristol-Meyers Squibb
- Covance
- GE Healthcare
- Genentech
- GlaxoSmithKline
- Eli Lilly and Company
- Lundbeck
- Merck
- Meso Scale Diagnostics
- Pfizer Inc.
- Piramal Imaging
- Roche CNS group
- Servier
- UCB
- Golub Capital
This publication has 30 references indexed in Scilit:
- Parkinson's disease tremor-related metabolic network: Characterization, progression, and treatment effectsNeuroImage, 2011
- Complex network measures of brain connectivity: Uses and interpretationsNeuroImage, 2010
- Imaging essential tremorMovement Disorders, 2010
- Temporal lobe changes in early, untreated Parkinson's diseaseMovement Disorders, 2009
- Complex brain networks: graph theoretical analysis of structural and functional systemsNature Reviews Neuroscience, 2009
- Hierarchical Organization of Human Cortical Networks in Health and SchizophreniaThe Journal of Neuroscience, 2008
- Structural Insights into Aberrant Topological Patterns of Large-Scale Cortical Networks in Alzheimer's DiseaseThe Journal of Neuroscience, 2008
- Parkinson's disease: clinical features and diagnosisJournal of Neurology, Neurosurgery & Psychiatry, 2008
- Efficiency and Cost of Economical Brain Functional NetworksPLOS Computational Biology, 2007
- A Resilient, Low-Frequency, Small-World Human Brain Functional Network with Highly Connected Association Cortical HubsThe Journal of Neuroscience, 2006